Description About Celularity Celularity Inc. (Nasdaq: CELU) is a longevity-focused regenerative and cellular medicine company developing and manufacturing allogeneic and autologous cell therapies derived from the postpar…
Skills: Standard Costing, Inventory Valuation, US GAAP, Month-end Close, General Ledger
Description About Celularity Celularity Inc. (Nasdaq: CELU) is a longevity-focused regenerative and cellular medicine company developing and manufacturing allogeneic and autologous cell therapies derived from the postpar…
Sign up with Clera and we'll reach out the moment a role actually fits you — no more spraying applications into the void.
$125k–$140k/yr
Full-time
bachelor degree, professional certificate
Posted 11d ago
~40 hrs/week
Responsibilities
Manage inventory valuation, standard costing, and the accounting for finished goods and raw materials. Oversee monthly close activities, inventory reserves, and coordinate annual physical inventories for external audits.
Requirements
Requires a Bachelor's degree in Accounting and at least 8 years of accounting experience in a manufacturing or distribution setting. Proficiency in US GAAP, standard costing systems, and ERP software is essential.
Full job description
Description
About Celularity
Celularity Inc. (Nasdaq: CELU) is a longevity-focused regenerative and cellular medicine company developing and manufacturing allogeneic and autologous cell therapies derived from the postpartum placenta. Celularity leverages the placenta’s unique biology, immunologic properties and scalable availability to develop therapeutic solutions targeting fundamental mechanisms of aging and age-related disease.
Ensure inventory is properly valued, inventory transactions are properly recorded and adequate inventory controls are in place
Manage the accounting for finished goods, raw materials/components, packaging, import/inbound/ outbound freight
Track and report inventory cost variances (PPV/OH/ etc.) and calculate, record and report adequate inventory variance capitalization adjustments
Responsible for developing standard costs and determining and accounting for revaluation of inventory
Perform in-depth analysis of direct manufacturing and overhead cost
Responsible for the reconciliation of various inventory-related balance sheet accounts
Responsible for implementing a cycle count process and recording and reconciling the results and the preparation of reconciliations of inventories held
Manage the development of inventory reserves for any slow moving and obsolete products
Responsible for the monthly close activities related to inventory transactions and the preparation and review of journal entries related to inventory, COGS and R&D
Prepare financial statement disclosures related to inventory and COGS
Liaise with the FP&A team to ensure budgeting is accurate and based on best information available
Coordinate with operations teams on the annual physical inventory to ensure successful external audit
Perform ad-hoc inventory reporting and analysis
This role is an individual contributor reporting into the Sr. Director, Accounting role
Requirements
Bachelor's degree in Accounting required; CPA strongly preferred;
8+ years of direct accounting experience within a manufacturing/distribution setting required; biotech or related industry experience a strong plus;
Must have experience with month-end close and general ledgers required;
Must have strong experience with establishing and maintaining standard costing system, inventory cost absorption and inventory revaluation procedures required.
Strong knowledge of US GAAP required;
Knowledge of Great Plains or similar ERP system required;
Advanced Excel skills and strong MS Office skills;
Demonstrated success in delivering quality results and overcoming obstacles in a time-sensitive environment;
Ability to juggle and prioritize multiple work streams while remaining effective under pressure;
Strong analytical, organizational and problem-solving skills;
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Degenerative Diseases
Industry
Biotechnology
Company size
51-200 employees
Founded
2016
Headquarters
Florham Park, NJ
LinkedIn followers
16,753
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature’s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases. To learn more visit celularity.com.
Offices: 170 Park Avenue, Florham Park, NJ 07932, US · 33 Technology Drive, Warren, New Jersey 07059, US
A next-gen Biotech company creating off-the-shelf cellular medicines for Cancer, Infectious, and Degenerative Diseases
Industry
Biotechnology
Company size
51-200 employees
Founded
2016
Headquarters
Florham Park, NJ
LinkedIn followers
16,753
Celularity, headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by delivering off-the-shelf allogeneic placenta-derived cellular therapies at unparalleled scale, quality and economics. Celularity’s innovative approach to cell therapy harnesses the unique therapeutic potential locked within the postpartum placenta. Through nature’s immunotherapy engine – the placenta – Celularity is leading the next evolution of cellular medicine with placenta-derived T cells, NK cells, and pluripotent stem cells to target unmet and underserved clinical needs in cancer, infectious and degenerative diseases. To learn more visit celularity.com.
Offices: 170 Park Avenue, Florham Park, NJ 07932, US · 33 Technology Drive, Warren, New Jersey 07059, US